Abstract
Introduction
Single or repetitive short periods of ischaemia followed by intermittent reperfusion, render the heart more resistant to a subsequent longer ischaemic period. This phe-Ž . nomenon, called ischaemic preconditioning IPC , limits w x infarct size 1-3 , reduces the risk of ischaemia-reperfuw x sion arrhythmias 4-6 , improves recovery of ventricular w x function 7,8 , reduces catabolites accumulation, and slows w x ischaemic metabolism 2 . This cardioprotective effect has w x been observed in different species, including rats 9,10 , w x w x w x w x rabbits 11 , dogs 1 , pigs 12 , and humans 13 . Some studies have demonstrated that ischaemia-reperfusion attenuated endothelial function in large coronary ves-) Ž . Ž . Corresponding author. Tel. q1-514 343 5909; Fax q1-514 343 2102; E-mail: lamontad@ere.umontreal.ca w x w x sels 14,15 and in coronary microvessels 16 . Some groups have demonstrated that the beneficial effect of IPC is not limited to the cardiomyocytes, but can be observed in endothelial cells in various experimental models including w x dog resistance coronary arteries in vivo 16 , and coronary w x arteries of the rat in vitro 17,18 . Adenosine has often been reported to be a mediator of the protection afforded w x by IPC 19, 20 . For example, we have recently demonstrated that blockade of adenosine-receptors with 8-phenyltheophylline can prevent the protection of the endothelial function afforded by IPC in the non-diabetic rat coronary w x bed 18 .
An early study reported that IPC can reduce infarct size w x in a non-insulin-dependent diabetic rat model in vivo 21 . On the other hand, IPC failed to reduce the incidence of ventricular arrhythmias and to improve cardiac function in w x diabetic rat hearts 22,23 . However, to the best of our knowledge, little is known about the effect of IPC on endothelial function in diabetic hearts, and whether exogenous adenosine perfusion can mimic the effects of IPC in this pathological model. Since diabetes has been associated w x with endothelial 24,25 and myocardial dysfunction w x 26,27 , as well as an altered sensitivity to ischaemic injury w x 28,29 , these unanswered questions are highly relevant.
Therefore, the first aim of the present study was to evaluate whether IPC affords protection against ischaemic injury to the endothelium of coronary vessels and to contractile function in isolated diabetic rat hearts. The second aim was to verify whether exogenous adenosine perfusion can mimic the beneficial effects of IPC against ischaemic injury in these hearts.
Methods

Preparation of hearts
The investigation was performed in accordance with the Canadian Council on Animal Care. Male Sprague-Dawley rats weighing 200-225 g were rendered diabetic or treated as vehicle control by injection into the tail vein of strepto-Ž y1 . Ž zotocin 55 mg kg or vehicle 0.1 N citrate buffer, pH . 4 .5 , resp ectiv ely , u n d er lig h t an aesth esia Ž . methoxyflurane . Animals were allowed free access to food and water at all times. After two months, diabetic rats and age-matched controls were narcotised with CO until 2 complete loss of consciousness and promptly decapitated. The thorax was rapidly opened and the heart excised and Ž y1 . immersed in ice-cold heparinised buffer 10 IU ml . It was immediately mounted on the experimental setup and perfused within 1 min after decapitation at constant flow by means of a digital roller pump. A 20 ml compliance chamber along the perfusion line ensured a continuous flow. The flow rate was adjusted during the stabilisation period to obtain a coronary perfusion pressure of approximately 75 mmHg and was held constant, with the exception of the ischaemic periods during which flow was either Ž .
y1 stopped zero-flow ischaemia or reduced to 1 ml min Ž . low-flow ischaemia . A second adjustment of the flow rate was made at the end of the long reperfusion period, before the perfusion of U-46619, to correct any deviation of the coronary perfusion pressure from 75 mmHg, and was held constant thereafter. constant temperature of 378C. All drugs were administered through a Y connector in the aortic cannula with syringe Ž . pumps Harvard Apparatus, model 11 at one hundredth of the coronary flow rate. Adequate mixing of the drugs was ensured by the turbulent flow created in the reverse drop shaped aortic cannula. All concentrations mentioned in the text and figures refer to the final concentration after mixing. Coronary perfusion pressure was measured with a pressure transducer connected to a side arm of the aortic perfusion cannula. Isovolumetric left ventricular pressure Ž . and its first derivative d Prdt was measured by a fluid filled latex balloon inserted into the left ventricle and connected to a second pressure transducer. The volume of the balloon was adjusted to obtain a diastolic pressure between 5 and 10 mmHg. Heart rate was derived from the left ventricular pressure trace by a tachograph. Data were Ž recorded on a polygraph system Grass Model 79 poly-. Ž graph . Body weight and blood glucose levels One Touch . II glucometer, Lifescan were measured at the time of decapitation.
Experimental protocols
Ž
The animals were randomised into twelve groups The hearts in all groups were subjected to a 20 min stabilisation period. Ischaemic groups were subjected to a 15 min sham period, followed by 30 min of partial is-Ž y1 . chaemia flow rate 1 ml min prior to a 20 min reperfu-Ž . sion period. In the preconditioned groups IPC , the hearts Ž . were exposed to 5 min global ischaemia zero flow plus Ž . 10 min of reperfusion IPC1 or 5 min global ischaemia Ž . plus 5 min of reperfusion repeated three times IPC3 before the 30 min ischaemia and 20 min reperfusion periods. The sham groups were not exposed to ischaemiareperfusion at all, but to a time-matched normal perfusion. After these periods, coronary arteries were precontracted with 0.1 mM U-46619 administered throughout the last phase of the experiment. Fifteen min after the beginning of U-46619 infusion, the endothelial function was evaluated Ž . with the vasodilation produced by 10 mM serotonin 5-HT , whereas coronary smooth muscle function was evaluated Ž . using 3 mM sodium nitroprusside SNP . These infusions were maintained for 10 min, which was long enough to reach a steady state. A washout period of 10 min was allowed between each infusion. Vasodilation was quantified by computing percent changes in coronary resistance Ž . coronary perfusion pressure divided by coronary flow , measured immediately before each drug infusion, and after a new steady state. The concentrations of 5-HT and SNP were determined in preliminary dose-response experiments to produce near-maximal vasodilation.
In additional experimental series, the effect of an adenosine perfusion was compared with that of IPC. In these groups, hearts were treated with either 3 mM adenosine or vehicle starting after either a 20 min or a 35 min stabilisation period, in order to expose the hearts to either 30 or 15 min adenosine perfusion before ischaemia. The adenosine perfusion lasted throughout the ischaemic period.
Statistical analysis
Values represent the mean " SEM. Statistical significance of differences between means was evaluated by a two way analysis of variance with Scheffe post-hoc test. In the presence of an interaction between the different groups, one way analysis of variance were used for each group. A Ž commercially available software Systat for Windows, ver-. Ž . sion 6.1 was used. Only probability values p smaller than 0.05 were considered to be statistically significant.
Drugs
Ž . All drugs were obtained from Sigma St. Louis, MA . A Ž 28.5 mM stock solution of U-46619 9,11-dideoxy-. 11a ,9a-epoxymethano-prostaglandin F was dissolved 2 a in 100% ethanol and diluted with 0.9% NaCl solution to obtain the desired final concentration. Ethanol at the con-Ž . centration obtained in the final dilution 0.003% , had no effect on any of the hemodynamic variables studied and on the dilator responses to 5-HT and SNP. All the other drugs were dissolved in Krebs-Henseleit buffer.
Results
A total of 42 non-diabetic rats and 43 diabetic rats have been used in the present study. Body weight of rats treated with streptozotocin or vehicle two months after injection was 365.3 " 10.1 and 558.9 " 13.7 g, respectively, p -0.05. Blood glucose level of these animals was 21.4 " 0.47 and 4.5 " 0.12 mmol l y1 respectively, p -0.05.
IPC groups
Vascular function
Coronary resistance of non-diabetic hearts measured Ž . just before 0.1 mM U-46619 perfusion n s 30 was 5.92 " 0.29 mmHg min ml y1 , for a coronary flow rate of y1 y1 Ž 6.72 " 0.22 ml min g mean heart weight of 1.90 " . Ž . 0.05 g . In diabetic hearts n s 29 , coronary resistance measured before 0.1 mM U-46619 perfusion was 4.99 " 0.32 mmHg min ml y1 , for a coronary flow rate of 7.38 " y1 y1 Ž . 0.36 ml min g mean heart weight of 2.04 " 0.06 g . Ž . Infusion of U-46619 0.1 mM, n s 59 induced a signifi-Ž . cant p -0.05 vasoconstriction in all groups of hearts Ž . sham, ischaemia, IPC1, and IPC3, Table 1 . Vasodilation produced by 10 mM 5-HT in sham hearts from diabetic Ž . rats y25.2 " 4.8% was comparable to that of age-Ž . matched control rats y25.2 " 3.3% . Thirty min of partial ischaemia significantly diminished the 5-HT-induced vasodilation by more than half in hearts from non-diabetic Ž . and diabetic rats Fig. 2 . One period of IPC in non-diabetic hearts prevented the deleterious effect of ischaemia on endothelium-dependent vasodilation: the vasodilation produced by 5-HT in preconditioned hearts was comparable to that observed in hearts not exposed to ischaemia Ž . Fig. 2 . In diabetic hearts, one period of IPC was insufficient to preserve the endothelial function. However, three periods of IPC prevented the deleterious effect of is- chaemia on endothelium-dependent vasodilation in dia-Ž . betic as well as in non-diabetic hearts Fig. 2 . Endothelium-independent vasodilation to 3 mM SNP was not affected by ischaemia and was found to be comparable in Ž the four groups of hearts sham, ischaemia, IPC1, and . Ž . IPC3 from diabetic and non-diabetic rats Fig. 2 . 
Myocardial function
The inotropic and lusitropic characteristics of diabetic hearts were comparable to that of non-diabetic hearts: Ž just before the 30 min ischaemic period y30.5 " 2.5% in Ž . non-diabetic hearts n s 12 and y28.1 " 3.2% in dia-. betic hearts, p -0.05, n s 14 . The perfusion rate in y1 y1 Ž non-diabetic hearts was 6.2 " 0.3 ml min g mean . heart weight of 2.31 " 0.09 g . In diabetic hearts, the y1 y1 Ž perfusion rate was 7.29 " 0.39 ml min g mean heart . Ž weight of 2.14 " 0.09 g . Infusion of U-46619 0. Ž . 10 mM 5-HT in non-diabetic hearts Fig. 4 . In contrast, Ž . only the 30 min pre-treatment with adenosine n s 7 preserved the vasodilation produced by 10 mM 5-HT in Ž . diabetic hearts Fig. 4 . Vasodilation to 3 mM SNP was Ž . comparable in all adenosine-treated hearts Fig. 4 . 
The 
Discussion
In the present study, we have evaluated whether IPC can exert a protective effect on myocardial function, and prevent endothelial cell dysfunction induced by ischaemia-reperfusion injury in the coronary circulation of diabetic and non-diabetic rats. The effect of exogenous adenosine perfusion was also evaluated. The major find-Ž . ings of this study are 1 that IPC with a single short period of ischaemia prevents endothelial dysfunction produced by ischaemia-reperfusion in non-diabetic hearts, Ž . whereas three periods are necessary in diabetic hearts, 2 IPC with 3 periods of ischaemia can improve the recovery Ž . of myocardial function after ischaemia in both groups, 3 adenosine perfusion starting 15 min before ischaemia can mimic the beneficial effect of IPC on endothelial function in non-diabetic coronary arteries, whereas a longer adeno-Ž . sine perfusion 30 min is obligatory for endothelial protection in diabetic hearts. Finally, the longer adenosine perfusion can also improve the recovery of contractile function after ischaemia in diabetic hearts.
The buffer-perfused, flow-controlled isolated heart was selected for the present study. This model allowed highly reproducible ischaemia and controlled reperfusion without any damage to the vessels by clamping or ligature procedures. However, oxygen transport by a buffer solution is less than that of blood, and a higher flow rate must be used to obtain a perfusion pressure within the physiological range. Since ischaemia-reperfusion can alter the coronary Ž dilatory reserve Bouchard and Lamontagne, unpublished . observation , preconstriction of coronary arteries with U-46619 allowed a more reliable assessment of endothelium-dependent and independent responses. Finally, all groups were time-matched to minimize the effect of time on our preparations.
Effect of preconditioning on endothelial dysfunction
In the present study, the vasodilation to 5-HT was used as an index of endothelial function. 5-HT has been shown to be an endothelium-dependent vasodilator in several w x isolated vessel preparations 30 as well as in isolated rat w x hearts 31 . In isolated hearts, the coronary vasodilation to 5-HT is blocked after treatment with NO-synthase inw x hibitors 31 . Thus, the vasodilatory response to 5-HT is indicative of the ability of endothelial cells to generate and release NO. The coronary vasodilation to 5-HT was not altered in diabetic rats. This is in contrast with several studies reporting impairment of endothelium-dependent relaxation in aorta from diabetic animals, including rabbits w x and rats 32,33 . However, other reports have shown no change in endothelium-dependent relaxation in diabetic w x animals 34,35 . This controversy may be explained by several variables like the animal species, the vascular bed studied, or the duration and severity of the pathology.
Our data show that endothelium-dependent vasodilation of coronary arteries to 5-HT is drastically decreased after ischaemia-reperfusion injury. However the same vessels retained the ability to dilate to SNP, an endothelium-independent vasodilator. This indicates that, under the present conditions, ischaemia-reperfusion altered selectively the functionality of the endothelium without affecting that of smooth muscle cells. IPC1 in non-diabetic hearts only, and IPC3 in all hearts, prevented the reduction in the vasodilation to 5-HT, suggesting that IPC can protect endothelial function in coronary arteries against the deleterious effect of ischaemia-reperfusion. A similar protective effect of IPC on endothelium-dependent acetylcholine-induced relaxation was observed in epicardial coronary arteries of w x normal dogs 16 , and in left coronary arteries in vitro w x isolated from non-diabetic rats 17 . In contrast, in an anaesthetized open-chest canine model, IPC could not prevent the reduction in both endothelium-dependent and independent dilator responses observed after one hour w x coronary occlusion and 4 hours of reperfusion 36 . However, it is currently unclear whether this discrepancy is species-related or due to a different severity of the ischaemic insult.
Effect of preconditioning on myocardial recoÕery
In our study, d Prdt and d Prdt , which represent max min the capacity of the ventricle to contract during systole and its ability to relax during diastole, were used to evaluate the contractile function of the hearts. The results of the w x present study as well as others 6,7 showed that IPC enhances functional recovery in isolated non-diabetic rat
not benefit from IPC. In the present study, however, an improved post-ischaemic ventricular recovery with IPC was observed in the diabetic rat model.
ProtectiÕe effect of exogenous adenosine
Adenosine has often been reported to be the endogew x nous mediator of the protection afforded by IPC 19, 20 . We have recently reported that the adenosine-receptor antagonist, 8-phenyltheophylline, prevents the protective effect of IPC on the endothelial function in the isolated rat w x heart 18 . Therefore, we tested whether a reduced sensitivity to the cardioprotective effect of adenosine in diabetic hearts could explain the more extensive IPC required in these hearts. Two pre-treatment regimens with exogenous adenosine were compared: adenosine perfusion started either 15 min before ischaemia, being temporally equivalent to IPC1 with 5 min ischaemia and 10 min reperfusion, or 30 min before ischaemia, corresponding to IPC3 with 3 cycles of 5 min ischaemia and 5 min reperfusion. In accordance, a longer pre-treatment with adenosine was Ž . required in diabetic hearts 60 vs. 45 min in order to prevent the ischaemia-induced reduction in the vasodilation to 5-HT. This difference is probably underestimated since we have recently observed that, in non-diabetic hearts, a 5 min treatment with 3 mM adenosine performed 10 min before ischaemia is sufficient to preserve the Ž vasodilation to 5-HT y28 " 1% vs. y25 " 4% for is-. chaemic and sham hearts, respectively, n s 4 per group . Thus, these data suggest that exogenous adenosine can mimic the protective effect of IPC on the endothelial function. In addition, the longer exposure to adenosine needed in diabetic hearts in order to observe a protective effect may explain the more extensive IPC required.
In contrast to the endothelial function, both the 45 min and 60 min adenosine pre-treatments were effective in improving the post-ischaemic recovery of d Prdt and max d Prdt in diabetic hearts. However, adenosine could min not significantly improve functional recovery in non-diabetic hearts. This is probably due to the fact that non-diabetic hearts recovered completely within the 20 min reperfusion, whereas functional recovery of diabetic hearts was blunted compared with control hearts. Therefore, the beneficial effect of adenosine will be more important in hearts with depressed ventricular function. The mechanisms by which adenosine can exert a cardioprotective effect are numerous. Adenosine, released from ischaemic tissues and acting on A receptors, can can be a mediator of the ischaemic preconditioning. The physiological role of A receptors is still poorly charac- 3 terised, but they have recently been implicated as activaw x tors of mast cells 49 . According to this hypothesis mast Ž cells would release mediators histamine, leukotrienes, free . radicals, thromboxanes, cytokines during the precondi-Ž . tioning period transient ischaemia or during exogenous adenosine perfusion, producing little or no damage to myocytes, as these are washed away too rapidly. During the subsequent prolonged ischaemic insult, depleted mast cells could no longer release these deleterious mediators, w x resulting in a reduced myocardial or vascular damage 50 . It remains to be established whether these mechanisms can also explain the protective effect of IPC or exogenous adenosine perfusion on endothelial and myocardial functions.
There is a strong controversy whether the diabetic heart w x w x is more 28 or less 29 sensitive to ischaemic injury. In the present study, no marker of ischaemic injury such as CK release was measured. Therefore, the severity of the ischaemic injury in diabetic and normal hearts cannot be compared. However, post-ischaemic ventricular recovery was blunted in diabetic hearts. On the other hand, diabetic hearts needed more IPC periods and longer adenosine perfusion, compared with non-diabetic hearts, to achieve the same level of protection to the endothelial function. Although the exact mechanism of this difference remains unknown, several hypotheses can be suggested. First, the signalling pathways activated by endogenous or exogenous adenosine may be affected in diabetic coronary vessels. Since PKC and K channels are involved in the cardio-ATP protective effect of IPC and adenosine, it is possible that an alteration of these mechanisms could explain the reduced sensitivity to the cardioprotective effect of IPC and adenosine observed in diabetic hearts. On the one hand, an attenuated PKC is unlikely, since many studies have reported an increased PKC activity along with higher diacylglycerol levels in vascular tissues of diabetic animals w x 51,52 . Furthermore, dose-response curves to the PKC activator, phorbol 12-myristate 13-acetate, performed in diabetic hearts were found to be comparable with that of Ž age-matched controls Bouchard and Lamontagne, unpub-. lished observation . On the other hand, reduced vascular responses to K channel activators in diabetes mellitus ATP w x have been reported 53,54 . We have also observed a reduced coronary dilation with lemakalim in diabetic hearts Ž . Bouchard and Lamontagne, unpublished observation . However, we cannot rule out that IPC in diabetic hearts involves activation of other pathways than those described for non-diabetic hearts.
These findings may have clinical implications. For example, during angioplasty or transplantation procedures, diabetic patients may need more ischaemic periods or a longer adenosine perfusion in order to achieve the same level of cardioprotection. However, it is certainly premature to extrapolate these findings to human beings and further experiments will be necessary.
In conclusion, these data suggest that ischaemic preconditioning or exogenous adenosine perfusion can afford protection to myocardial and endothelial function against subsequent ischaemic injury in diabetic hearts. However, to achieve the same degree of endothelial protection, preconditioning must be more extensive and adenosine perfusion period be longer in diabetic hearts, compared with non-diabetic hearts.
